camostat has been researched along with Cholelithiasis in 2 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimoda, I | 2 |
Ishizuka, H | 1 |
Murakami, M | 1 |
Sato, K | 2 |
Hirano, H | 2 |
Tanno, N | 2 |
Ohira, C | 1 |
Koizumi, M | 2 |
Toyota, T | 2 |
Ishizuka, J | 1 |
2 other studies available for camostat and Cholelithiasis
Article | Year |
---|---|
[A new experimental trial for dissolution of gallbladder stones].
Topics: Animals; Cholelithiasis; Cholesterol; Cricetinae; Deoxycholic Acid; Drug Therapy, Combination; Ester | 1989 |
Combination therapy of trypsin inhibitor with ursodeoxycholic acid on cholesterol gallbladder stone.
Topics: Cholelithiasis; Cholesterol; Deoxycholic Acid; Drug Therapy, Combination; Esters; Gabexate; Guanidin | 1989 |